TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

Halifax-based medtech startup Sound Blade has secured $16.5 million USD ($23.8 million CAD) in Series A funding to develop ...

Hundreds of a people who have chronic liver disease are being helped by an NHS trust's service that helps them attend vital appointments. University Hospital Southampton (UHS) said its project, called ...

Researchers destroy cancer cells with ultrasound treatment Jun 24, 2020 Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression ...

Budd-Chiari syndrome (BCS) is a group of rare conditions in which veins in the liver become blocked. An ultrasound for BCS may show atypical, narrowed, or potentially blocked veins inside the liver.

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Long classified as a subset of common liver cancer, FLC should be considered its own unique disease. Now researchers are testing a combination drug therapy that targets FLC tumors. Like many rare ...